Clinical Trial: A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07590193) titled 'A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus' on May 11.

Brief Summary: The main objective of this trial is to assess the safety and tolerability of AMG 127 as single dose and multiple doses in healthy participants and participants with type 2 diabetes mellitus (T2DM).

Study Start Date: June 15

Study Type: INTERVENTIONAL

Condition: Diabetes Mellitus, Type 2

Intervention: DRUG: AMG 127

AMG127 will be administered as either a SC injection or as an IV infusion.

DRUG: Placebo

Placebo will be administered as either a SC injection or as an IV infusion.

Recruitment Status: NOT_Y...